Jiangxi Lihuo Biotechnology

Jiangxi Lihuo Biotechnology is a high-tech enterprise specializing in the development of rapid molecular diagnostic technologies. The company is centered around its proprietary Enzymatic Recombinase Amplification (ERA) platform, which enables highly sensitive and specific nucleic acid detection under isothermal conditions. This technology bypasses the need for complex thermal cycling equipment, making it ideal for point-of-care testing (POCT) in diverse environments. Lihuo Biotech's product portfolio spans human clinical diagnostics, veterinary health, and food safety testing, with a particular focus on infectious disease pathogens. By providing efficient and portable diagnostic solutions, the company supports rapid clinical decision-making and public health surveillance.